Marker Therapeutics Inc (MRKR)
3.70
+0.18
(+5.11%)
USD |
NASDAQ |
Nov 05, 16:00
3.70
0.00 (0.00%)
After-Hours: 16:03
Marker Therapeutics Shareholders Equity (Quarterly): 9.703M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 9.703M |
March 31, 2024 | 11.79M |
December 31, 2023 | 14.05M |
September 30, 2023 | 16.71M |
June 30, 2023 | 19.03M |
March 31, 2023 | 15.91M |
December 31, 2022 | 19.60M |
September 30, 2022 | 22.60M |
June 30, 2022 | 28.03M |
March 31, 2022 | 35.71M |
December 31, 2021 | 43.99M |
September 30, 2021 | 52.28M |
June 30, 2021 | 63.24M |
March 31, 2021 | 72.49M |
December 31, 2020 | 27.34M |
September 30, 2020 | 30.60M |
June 30, 2020 | 34.51M |
March 31, 2020 | 39.50M |
December 31, 2019 | 44.09M |
September 30, 2019 | 47.88M |
June 30, 2019 | 51.40M |
March 31, 2019 | 55.61M |
December 31, 2018 | 59.34M |
September 30, 2018 | 0.6905M |
June 30, 2018 | 4.144M |
Date | Value |
---|---|
March 31, 2018 | 0.616M |
December 31, 2017 | 3.658M |
September 30, 2017 | 5.936M |
June 30, 2017 | 8.566M |
March 31, 2017 | 4.141M |
December 31, 2016 | 6.185M |
September 30, 2016 | 7.494M |
June 30, 2016 | -19.33M |
March 31, 2016 | -25.70M |
December 31, 2015 | -21.36M |
September 30, 2015 | -2.621M |
June 30, 2015 | -9.813M |
March 31, 2015 | -1.766M |
December 31, 2014 | -1.024M |
September 30, 2014 | -0.6562M |
June 30, 2014 | -2.563M |
March 31, 2014 | -5.506M |
December 31, 2013 | -8.768M |
September 30, 2013 | -5.103M |
June 30, 2013 | -4.770M |
March 31, 2013 | -5.501M |
December 31, 2012 | -6.042M |
September 30, 2012 | -4.368M |
June 30, 2012 | -3.817M |
March 31, 2012 | -3.606M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
9.703M
Minimum
Jun 2024
72.49M
Maximum
Mar 2021
31.64M
Average
28.03M
Median
Jun 2022
Shareholders Equity (Quarterly) Benchmarks
AIM ImmunoTech Inc | 6.102M |
Perspective Therapeutics Inc | 341.00M |
Protalix BioTherapeutics Inc | 28.58M |
Electromed Inc | 44.54M |
Armata Pharmaceuticals Inc | -46.10M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 11.68M |
Total Liabilities (Quarterly) | 1.972M |